CSIMarket
 


Humanigen Inc  (HGEN)
Other Ticker:  
 

Cumulative Humanigen Inc's Quick Ratio for Trailing Twelve Months Period

HGEN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

HGEN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 11.17 % 53.02 % 33.66 % 236.64 % 362.1 %
Y / Y Cash & cash equivalent Growth -67.68 % -60.97 % -25.78 % 3.36 % -16.33 %
Quick Ratio for Trailing Twelve Months Period 0.72 0.92 1.3 1.49 1.86
Total Ranking # 1864 # 2328 # 2039 # 2010 # 1341
Seq. Current Liabilities Growth -0.78 % 8.16 % 3.57 % 0.02 % 36.56 %
Seq. Cash & cash equivalent Growth -47.45 % -31.77 % -1.53 % -8.48 % -36.53 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $76 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.72 below Humanigen Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 411 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Humanigen Inc. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 1864, from total ranking in previous quarter at 2328.

What is Quick Ratio?
Learn more about HGEN
Quick Ratio HGEN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 412
Sector # 782
S&P 500 # 1863


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.78 2.11 0.03
(Sep. 30, 2014)   (Mar 31 2020)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Pacira Biosciences inc   1.97 
Horizon Therapeutics Public Limited Company  1.97 
Avalo Therapeutics Inc   1.97 
Exicure Inc   1.97 
Applied Therapeutics Inc   1.96 
Rigel Pharmaceuticals Inc  1.95 
Universe Pharmaceuticals Inc  1.94 
Intelgenx Technologies Corp   1.93 
Checkpoint Therapeutics inc   1.92 
Nrx Pharmaceuticals Inc   1.88 
Procyon Corp  1.88 
Fibrogen Inc   1.87 
Aptorum Group Limited  1.86 
Myovant Sciences Ltd   1.84 
Aptevo Therapeutics Inc   1.82 
Hillstream Biopharma Inc.  1.80 
Cti Biopharma Corp   1.79 
Avid Bioservices Inc.  1.79 
Novabay Pharmaceuticals Inc   1.78 
Zealand Pharma A  1.78 
Evolus Inc   1.74 
2seventy Bio Inc   1.73 
Macrogenics Inc   1.72 
Ibio inc   1.70 
Elite Pharmaceuticals Inc.  1.69 
Adamis Pharmaceuticals Corp  1.66 
Prophase Labs Inc   1.65 
Nabriva Therapeutics Plc  1.63 
Heron Therapeutics Inc   1.63 
Panbela Therapeutics Inc   1.62 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

QUBT's Profile

Stock Price

QUBT's Financials

Business Description

Fundamentals

Charts & Quotes

QUBT's News

Suppliers

QUBT's Competitors

Customers & Markets

Economic Indicators

QUBT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071